Trium Capital LLP Abbott Laboratories Transaction History
Trium Capital LLP
- $350 Million
- Q3 2024
A detailed history of Trium Capital LLP transactions in Abbott Laboratories stock. As of the latest transaction made, Trium Capital LLP holds 69,962 shares of ABT stock, worth $8.21 Million. This represents 2.28% of its overall portfolio holdings.
Number of Shares
69,962
Previous 62,431
12.06%
Holding current value
$8.21 Million
Previous $6.49 Million
22.95%
% of portfolio
2.28%
Previous 0.82%
Shares
8 transactions
Others Institutions Holding ABT
# of Institutions
3,185Shares Held
1.3BCall Options Held
8.74MPut Options Held
8.08M-
Vanguard Group Inc Valley Forge, PA168MShares$19.7 Billion0.35% of portfolio
-
Black Rock Inc. New York, NY131MShares$15.4 Billion0.31% of portfolio
-
State Street Corp Boston, MA76.7MShares$9 Billion0.36% of portfolio
-
Capital International Investors Los Angeles, CA65.7MShares$7.72 Billion1.49% of portfolio
-
Capital Research Global Investors Los Angeles, CA53.3MShares$6.26 Billion1.31% of portfolio
About ABBOTT LABORATORIES
- Ticker ABT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,751,219,968
- Market Cap $206B
- Description
- Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...